日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of vessel morphology on CT-derived fractional-flow-reserve in non-obstructive coronary artery disease in right coronary artery

血管形态对右冠状动脉非阻塞性冠状动脉疾病中CT衍生的血流储备分数的影响

Tsugu, Toshimitsu; Tanaka, Kaoru; Belsack, Dries; Nagatomo, Yuji; Tsugu, Mayuko; Argacha, Jean-François; Cosyns, Bernard; Buls, Nico; De Maeseneer, Michel; De Mey, Johan

A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma

针对肝细胞癌的肿瘤内皮细胞特异性microRNA替代疗法

Hideki Iwamoto, Hiroyuki Suzuki, Atsutaka Masuda, Takahiko Sakaue, Toru Nakamura, Toshimitsu Tanaka, Miwa Sakai, Yasuko Imamura, Hirohisa Yano, Takuji Torimura, Hironori Koga, Kaori Yasuda, Masakatsu Tsurusaki, Takahiro Seki, Takumi Kawaguchi

Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma

胰液衍生的 microRNA-4516 和 microRNA-4674 作为胰腺导管腺癌的新型生物标志物

Takahiko Sakaue, Hironori Koga, Hideki Iwamoto, Toru Nakamura, Atsutaka Masuda, Toshimitsu Tanaka, Hiroyuki Suzuki, Hideya Suga, Shingo Hirai, Toru Hisaka, Yoshiki Naito, Keisuke Ohta, Kei-Ichiro Nakamura, Karuppaiyah Selvendiran, Yoshinobu Okabe, Takuji Torimura, Takumi Kawaguchi

Comparative Efficacy of ALK Inhibitors for Treatment-Naïve ALK-Positive Advanced Non-Small Cell Lung Cancer with Central Nervous System Metastasis: A Network Meta-Analysis

ALK抑制剂治疗初治ALK阳性伴中枢神经系统转移晚期非小细胞肺癌的疗效比较:一项网络荟萃分析

Ando, Koichi; Manabe, Ryo; Kishino, Yasunari; Kusumoto, Sojiro; Yamaoka, Toshimitsu; Tanaka, Akihiko; Ohmori, Tohru; Sagara, Hironori

Impact of coronary bifurcation angle on computed tomography derived fractional flow reserve in coronary vessels with no apparent coronary artery disease

冠状动脉分叉角度对无明显冠状动脉疾病的冠状动脉血管CT衍生的血流储备分数的影响

Tsugu, Toshimitsu; Tanaka, Kaoru; Nagatomo, Yuji; Belsack, Dries; Devos, Hannes; Buls, Nico; Cosyns, Bernard; Argacha, Jean-François; De Maeseneer, Michel; De Mey, Johan

Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors

肿瘤衍生的胰岛素样生长因子结合蛋白-1 导致肝细胞癌对酪氨酸激酶抑制剂产生耐药性

Hiroyuki Suzuki, Hideki Iwamoto, Takahiro Seki, Toru Nakamura, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Yasuko Imamura, Takashi Niizeki, Masahito Nakano, Shigeo Shimose, Tomotake Shirono, Yu Noda, Naoki Kamachi, Miwa Sakai, Kazutoyo Morita, Masamichi Nakayama, Tomoharu Yoshizumi, Ryoko K

Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab

病例报告:接受 FOLFIRI 联合贝伐单抗治疗的不可切除结直肠癌血液透析患者血清贝伐单抗浓度变化

Toshimitsu Tanaka, Hiroyuki Suzuki, Tomoyuki Ushijima, Sachiko Nagasu, Yoshito Akagi, Takumi Kawaguchi, Keisuke Miwa

Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments

索拉非尼联合节拍化疗 S-1 治疗晚期肝细胞癌的临床前及临床疗效及耐受性评估

Hiroyuki Suzuki, Hideki Iwamoto, Masahito Nakano, Toru Nakamura, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Dan Nakano, Ryoko Kuromatsu, Takashi Niizeki, Shusuke Okamura, Shigeo Shimose, Tomotake Shirono, Yu Noda, Naoki Kamachi, Hirohisa Yano, Atsushi Kawaguchi, Hironori Koga, Takuji Torim

Comparative Efficacy and Safety of Immunotherapeutic Regimens with PD-1/PD-L1 Inhibitors for Previously Untreated Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

PD-1/PD-L1抑制剂免疫治疗方案治疗既往未接受治疗的广泛期小细胞肺癌的疗效和安全性比较:系统评价和网络荟萃分析

Ando, Koichi; Manabe, Ryo; Kishino, Yasunari; Kusumoto, Sojiro; Yamaoka, Toshimitsu; Tanaka, Akihiko; Ohmori, Tohru; Ohnishi, Tsukasa; Sagara, Hironori

Promotion of liver regeneration and anti‑fibrotic effects of the TGF‑β receptor kinase inhibitor galunisertib in CCl4‑treated mice

TGF-β 受体激酶抑制剂 galunisertib 在 CCl4 治疗小鼠中促进肝再生和抗纤维化作用

Atsutaka Masuda, Toru Nakamura, Mitsuhiko Abe, Hideki Iwamoto, Takahiko Sakaue, Toshimitsu Tanaka, Hiroyuki Suzuki, Hironori Koga, Takuji Torimura